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Abstract
Objectives: We are presenting our experience collected from a series of 109 cases with SCC of the lower lip focus-
ing on clinical features of patients and surgical approach.
Study Design: We retrospectively analyzed medical records of patients diagnosed with Squamous Cell Carcinoma 
(SCC) of the lower lip at the Oral and Maxillofacial surgery at Xi’an Jiaotong University during a period between 
1999 and 2008.
Results: A total of 109 patients with lip cancer were included in the study. When no frozen-section test was per-
formed, the neoplasia was removed with a margin of at least 6 mm. Different surgical techniques were used for lip 
reconstruction after tumor excision. Neck dissection was performed in all patients with clinically palpable lymph 
nodes. Median follow-up was 38 months. During follow-up, recurrence occurred in 5 patients, 3 patients devel-
oped neck metastases, distant metastases developed in 1 patient. Five patients died during observation period.
Conclusions: The patient-related and defect-related issues must be taken into consideration during reconstruction 
for surgical defect. For N0 patients, we recommend wait-and-see policy. Early detection, careful follow-up and 
prompt neck is essential for the successful treatment. 
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Introduction
Lip cancer is a common malignancy of the oral cavity 
and accounts for 23.6% to 30% of malignant tumors of 
the oral cavity (1-5). The most frequent malignancy re-
lated to the lips is squamous cell carcinoma (SCC), while 
adenocarcinomas and melanoma occur rarely (3,4). The 
lower lip was the most frequently affected site, which 
accounts for more than 90% of the cases (2,6). 
SCC of the lip is thought to be related to sun exposure. 
It also explains the greater frequency of the pathologic 
findings on the lower than on the upper lip, because the 
upper lip is far less exposed to the sun than the lower 
(7). However, the etiology of lip cancer is multifacto-
rial, including exposure to sunlight, tobacco, genetic 
predisposition, immunosuppression and immunodefi-
ciency (7,8). The definitive pathogenic pathway remains 
unclear.
Surgery is the treatment of choice for most of the tumors 
of the lip. Surgical resection requires a full-thickness 
resection of the skin, muscle and underlying mucosa 
to allow a safe surgical margin. Numerous reconstruc-
tion methods after tumor removal have been reported, 
however, the reconstruction of lip defect remains a 
challenge (9). Neck dissection should be performed pa-
tients with N+ disease, although there is some debate 
about the measures that should be adopted in N0 cases 
(1,8,10,11).
In this work we are presenting our experience collected 
from a series of 109 cases with SCC of the lower lip 
from January 1999 to April 2008 focusing on clinical 
features of patients and surgical approach.
Material and Methods
A retrospective chart review was performed to analyze 
patients with a diagnosis of SCC of the lower lip treated 
in the Department of oral and maxillofacial surgery, 
Xi’an JiaoTong University stomatological hospital, from 
January 1999 through April 2008. 
One hundred and nine patients with preoperative di-
agnosis of SCC of the lower lip were identified in the 
medical records within this period. The charts were 
reviewed, and the following information was recorded: 
Age and sex, smoking habits and sun exposure, clinical 
stage, macroscopic features of the primary lesions, type 
of surgical treatment, follow-up, and outcome.
Analysis of the data was performed using the statistical 
package software SPSS 13.0 (SPSS Inc., Chicago, IL, 
USA).
Results
A total of 109 patients with lip cancer were included in 
the study. There were 87 men (79.8%) and 22 women 
(20.2%). The overall male-to-female ratio was 4 to 1. 
Mean patient age was 62.5 years (range, 32 to 83 years). 
Distribution of patients according to age is presented in 
table 1. SCC of the lower lip was more frequently found 
between the ages of 61 and 70 years (45/109, 41.3%). 
There were 47 patients (43.1%) had the risk factor of sun 
exposure (farmers), 16 patients (14.7%) smoked more 
than 10 cigarettes per day.
The right side of the lower lips was involved in 34 patients 
(31.2%), left side in 27 patients (24.8%), while in 48 pa-
tients (44.0%) the tumor involved both sides of the lips.
The distribution of postsurgical TNM stage is shown 
in table 1. There were 39 patients (35.8%) in stage T1, 
 Characteristics No. % 
Age ? 50 14 12.8 
51-60 27 24.8 
61-70 45 41.3 
71-80 20 18.3 
>80 3 2.8 
Gender male 87 79.8 
female 22 20.2 
TNM stage  
T stage 
   
             1   39 35.8 
2 52 47.7 
3 16 14.7 
4 2 1.8 
      N stage 0 87 79.8 
1 19 17.4 
2 3 2.8 
3   
      M stage 0 109 100 
1 0 0 
Site right side 34 31.2 
 left side 27 24.8 
 both sides 48 44 
Table 1. Patient and tumor characteristics.
52 (47.7%) in T2, and 16 patients (14.7%) were in T3 
stage. In 2 patients (1.8%) the lesion was in stage T4; 14 
patients (12.8%) presented with nodal disease at diag-
nosis. while in 95 patients (87.2%) there were no signs 
of clinical regional lymphadenopathy. All patients were 
in M0. We observed a close relationship between the 
tumor size at presentation and the neck stage. Two pa-
tients with T1-2 disease (2/91) developed lymph node 
metastases during the follow-up period. In contrast, 6 
of 18 patients with T3-4 disease developed lymph node 
metastases during the study period.
Neck dissection was performed in all patients with clin-
ically palpable lymph nodes (14/109, 12.8%): 3 patients 
(21.4%) underwent radical neck dissection(RND), 11 
patients (78.6%) underwent rational radical neck dis-
section with conservation of the external jugular vein, 
deep branches of the cervical plexus, and sternocleido-
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mastoid muscle (12). For the 8 patients who were N0 
at diagnosis and who developed lymph node metasta-
sis during the follow-up period, RND were performed 
in 5, bilateral RND were performed in 2, and radical 
neck dissection (RND) and contralateral supraomohy-
oid neck dissection were performed in 1. All the N+ pa-
tients were given postoperative radiotherapy.
Different surgical techniques were used for lip recon-
struction after tumor excision. For 36 patients (33%) 
with defects less than one third the length of the lower 
lip, we used a U or V, W- shape excision. For 56 patients 
(51.4%) with defects between one third and two thirds 
lip length of the lower lip, we performed Abbe flap, Ber-
nard flap, Karapandzic flap. For 17 patients (15.6%) with 
defects more than two thirds lip length of the lower lip, 
Bernard technique and cheek advancement flaps was 
used for reconstruction (Figs. 1,2).
Median follow-up was 38 months (range, 12 to 76 
months). During follow-up, local recurrence occurred 
in 5 patients, 3 patients developed neck metastases, 6 of 
whom were salvaged with surgery and/or radiotherapy. 
Fig.1. A) Bernard technique for the more than two thirds of the lower 
lip defect. B) Flap sutured. C) Postoperative result.
Fig. 2. A) Cheek advancement flaps for lower lip reconstruction. B) 
Postoperative result. C) Scar ectomy and reconstruction of vermilion 
of the lower lip in the two-stage operation(one year after the first 
operation).
Distant metastases developed in 1 patient. Five patients 
died during the observation period, 3 of causes unre-
lated to the disease treated, 2 of the patients died of lip 
cancer.
Discussion
Lip cancer is common in malignant neoplasm of the 
oral cavity. It also has been reported the most common 
malignant neoplasm of the oral cavity or the second fre-
quency skin cancer in the head and neck region in some 
studies (8,13). The lower lip was the most frequently af-
fected site. The predilection for this subsite has been 
attributed to sun exposure, because the lower lip re-
ceives considerably more direct sunlight than the up-
per lip. Sunlight and smoking are substantiated as risk 
factors for lip cancer development by epidemiological 
data (14,15). The sex distribution revealed only a slight 
tendency toward men, which is in contrast to previous 
studies that reported a male-to-female ratio of 5–8:1 
(1,8,10,16).
Several methods for treatment of SCC of the lip are 
available, including surgery, radiotherapy, chemother-
apy, and combinations of these. We preferred surgical 
removal of the tumor followed by the reconstruction of 
lip defects for most patients with SCC of the lip. All 
the patients underwent the surgical treatment in this 
series. The main goal of the surgery is to completely 
remove the tumor and the surgical treatment involves 
full-thickness of the skin, muscle and underlying mu-
cosa to allow a safe surgical margin.
At present, there is no consensus on the definition of 
an adequate margin of resection. It has been reported 
that a 3 mm margin with excision of early SCC of lower 
lip (stage I/II) seems to be appropriate, when a frozen-
section test of the margins is performed (17). If it is not 
performed, a 6 mm margin is necessary (17). Brodland 
et al. (18) recommended at least a 6 mm margin for 
high-risk tumors of primary cutaneous squamous cell 
carcinoma. Some surgeons consider a minimum of 10 
mm additional normal tissue at all margins of the resec-
tion (16). In this series, when no frozen-section test was 
performed, we kept a margin of 6-10 mm.
The lips play a key role in facial expression, speech, and 
eating. The goal of lip reconstruction for the surgical 
defect should be to maintain oral competence and maxi-
mize cosmesis. There are many techniques have been 
reported for lip reconstruction. However, as a result of 
the unique anatomy of the lips, reconstruction of the lip 
can be challenging, especially for the large defect.
Based our experience, a wedge-shaped or V-shaped ex-
cision for smaller tumors can be perform for less than 
one third the length in lower lip defects. If necessary to 
allow for adequate resection margins, we prefer the U-
shaped excisions. They are simple to perform and pro-
vide good results. 
It may be a challenge for the surgeon on making decision 
for the defects that are between one third and two thirds 
the length in low lip. The abbe flap (9), Karapandzic flap 
(19), Staircase technique (20,21), Gillies fan flap (9,22) 
and Bernard technique and its modifications (23,24) has 
been reported to be used for reconstructions involving 
up to two thirds of the lower lip. According to the size 
and location of the defect, local tissue characteristics, 
individual needs of the patient and patient’s condition, 
we performed local sliding flap, Abbe flap, Bernard 
technique, Karapandzic flap for 56 patients with defects 
between one third and two thirds lip length of the lower 
lip. In our experience, the local sliding flap is easy to 
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performed and suitable to the small tumors; the Abbe 
flap is used for defects medial to the commissure and 
could results in a proportional reduction in the size of 
both the upper and the lower lip, however it need for 
a two-stage procedure; The Karapandzic flap preserves 
the nerve and bloody supply but may result in micros-
tomia and distortion of the commissure when used for 
large defect; Bernard Technique and its several modifi-
cations could be used for large defect and the functional 
and aesthetic result outcome was acceptable. Although 
not commonly used, the staircase technique has been 
reported extremely practical and offers good aesthetic 
and functional results for the up to two thirds defect of 
the lower lip in several study (1,10,20,21). 
For the more than two thirds of the lower lip defect, we 
used Bernard technique and cheek advancement flaps. 
Generally, immediate reconstruction after resecting 
more than two thirds of the lower lip gives poor results. 
We consider most of these patients need secondary sur-
gery and the result is acceptable. Generally, we don’t 
recommend the free flap for reconstruction of lower lip, 
because of the poor appearance and function.
There is no standard or most acceptable surgical tech-
nique in lip reconstruction and there was little detailed 
assessment on postoperative functional and aesthetic 
outcome for patients following a lip reconstruction 
in current literature. However, the patient-related and 
defect-related issues must be taken into consideration 
during treatment planning.
The reported rate of lymph node metastases at diagno-
sis is 3% to 29% (1,8,10). In this study, 12.8% of all pa-
tients had lymph node involvement at diagnosis. There 
were 8 N0 cases that became positive during the follow-
up period, the percentage with lymph node metastases 
increased to 20.2%. Many studies have indicated a re-
markable worsening of the survival rate for cases that 
become N+ during follow-up (25). Therefore, how to 
treat patients with clinical stage N0 disease is in con-
troversy. Some surgeons have adopted an aggressive 
approach, they suggested that a prophylactic neck dis-
section should be performed in all N0 cases (11,26,27). 
Some other authors recommend the “wait-and-see” ap-
proach, proceeding to therapeutic RND and radiothera-
py, if necessary (8).
We consider it is important to identify the patients who 
will definitely benefit from an aggressive approach to 
the lymph nodes. The high risk of lymph node metas-
tases such as tumor size, high histologic grade, locally 
recurrent, perineural invasion in N0 cases has been re-
ported (4,10,28-30). However, it was found that the tu-
mor size does not correlate closely with regional lymph 
node metastases in other study (8). In this study, We 
also observed a close relationship between the tumor 
size and the neck stage at presentation. Two patients 
with T1-2 disease (2/91) developed neck metastases dur-
ing the follow-up period. In contrast, 6 of 18 patients 
with T3-4 disease developed neck metastases during 
the study period. JPM Vanderlei et al observed high in-
cidence of neck metastases (more than 20%) in tumors 
measuring 3 to 4 cm. They suggest that prophylactic 
neck dissection should be indicated in lip SCCs larger 
than 3 cm (31){Vanderlei, 2013 #528}.We recommend 
the ultrasound-guided wait-and-see policy for T1-2 pa-
tients with a clinical N0 neck. Certainly compliance of 
the patient is required.
Early detection and treatment could lead to decreased 
morbidity and mortality. Therefore, the role of dentists 
is very important in the early diagnosis of SCC of the 
lip. Because most of the tumors were diagnosed early 
(83.5%), SCC of the lip generally has a good outcome. 
Careful follow-up and prompt neck treatment remain 
important steps in the surgical management of patients 
with SCC of the lower lip.
Conclusions
Lower lip cancer is a frequent disease of the oral cavity. 
General agreement has not been reached concerning in 
lower lip reconstruction and unresolved questions re-
main with regard to N0 treatment. We report a series of 
109 patients and our experiences on surgical manage-
ment of SCC of the lower lip. The patient-related and de-
fect-related issues must be taken into consideration dur-
ing lip reconstruction. For N0 patients, we recommend 
wait-and-see policy. Careful follow-up and prompt neck 
treatment remain important steps. Early detection is es-
sential for the successful treatment of SCC of the lip.
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